KR910006229B1 - 악성 증식을 발견하기 위한 방법 - Google Patents

악성 증식을 발견하기 위한 방법 Download PDF

Info

Publication number
KR910006229B1
KR910006229B1 KR1019850700214A KR850700214A KR910006229B1 KR 910006229 B1 KR910006229 B1 KR 910006229B1 KR 1019850700214 A KR1019850700214 A KR 1019850700214A KR 850700214 A KR850700214 A KR 850700214A KR 910006229 B1 KR910006229 B1 KR 910006229B1
Authority
KR
South Korea
Prior art keywords
serum
methods
samples
tumor
healthy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019850700214A
Other languages
English (en)
Korean (ko)
Other versions
KR850700158A (ko
Inventor
아담 코박스
Original Assignee
아담 코박스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU8478A external-priority patent/HU191105B/hu
Application filed by 아담 코박스 filed Critical 아담 코박스
Publication of KR850700158A publication Critical patent/KR850700158A/ko
Application granted granted Critical
Publication of KR910006229B1 publication Critical patent/KR910006229B1/ko
Expired legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57505—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the blood, e.g. leukaemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Measurement Of Radiation (AREA)
KR1019850700214A 1984-01-12 1985-01-09 악성 증식을 발견하기 위한 방법 Expired KR910006229B1 (ko)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
HU84-78 1984-01-12
HU8478A HU191105B (en) 1984-01-12 1984-01-12 Method for detecting malignant proliferation
HU2251-78/84 1984-01-12
HU2251-1129/84 1984-03-21
HU84-1129 1984-03-21
HU112984 1984-03-21
PCT/HU1985/000001 WO1985003131A1 (en) 1984-01-12 1985-01-09 Method for detecting malign proliferation

Publications (2)

Publication Number Publication Date
KR850700158A KR850700158A (ko) 1985-10-25
KR910006229B1 true KR910006229B1 (ko) 1991-08-17

Family

ID=26317154

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850700214A Expired KR910006229B1 (ko) 1984-01-12 1985-01-09 악성 증식을 발견하기 위한 방법

Country Status (18)

Country Link
EP (1) EP0172841B1 (enExample)
KR (1) KR910006229B1 (enExample)
AU (1) AU585850B2 (enExample)
BR (1) BR8504686A (enExample)
CA (1) CA1265027A (enExample)
CS (1) CS273160B2 (enExample)
DE (1) DE3579200D1 (enExample)
DK (1) DK161915C (enExample)
ES (1) ES8705632A1 (enExample)
FI (1) FI84300C (enExample)
GR (1) GR850042B (enExample)
IL (1) IL74256A (enExample)
IT (1) IT1217292B (enExample)
MA (1) MA20326A1 (enExample)
NZ (1) NZ210799A (enExample)
PL (1) PL251506A1 (enExample)
PT (1) PT79826B (enExample)
WO (1) WO1985003131A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2086785C (en) * 1992-10-14 2008-10-07 Calum Macaulay Automated detection of cancerous or precancerous tissue by measuring malignancy associated changes (macs)
RU2235323C2 (ru) * 2002-05-14 2004-08-27 Российский НИИ геронтологии Способ диагностики злокачественных новообразований
HU0402428D0 (en) * 2004-11-24 2005-01-28 Navigator Tv Kft Method for computational comparative examination of momentary activity and state of the immune system by dried blood serum
EP3461326A1 (de) 2017-09-28 2019-04-03 Josef Wimmer Hagel- und sonnenschutzvorrichtung für den hopfenanbau

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2967534D1 (en) * 1978-07-07 1985-11-28 Bogoch Samuel Product for detecting the presence of cancerous or malignant tumor cells
DE2844217A1 (de) * 1978-10-11 1980-04-24 Popp Fritz Albert Verfahren zur diagnose und gezielten therapie von malignen tumoren
WO1985001960A1 (en) * 1983-10-31 1985-05-09 Livcell Analysis, Inc. Improved method of live blood cell analysis

Also Published As

Publication number Publication date
EP0172841B1 (en) 1990-08-16
IT8519043A0 (it) 1985-01-08
DK359685D0 (da) 1985-08-07
FI853481A0 (fi) 1985-09-11
PT79826A (en) 1985-02-01
IT1217292B (it) 1990-03-22
ES8705632A1 (es) 1987-05-01
AU3881385A (en) 1985-07-30
DK161915B (da) 1991-08-26
CS24185A2 (en) 1990-07-12
EP0172841A1 (en) 1986-03-05
PT79826B (en) 1986-10-28
AU585850B2 (en) 1989-06-29
GR850042B (enExample) 1985-04-10
KR850700158A (ko) 1985-10-25
DK359685A (da) 1985-08-07
PL251506A1 (en) 1985-09-24
FI84300B (fi) 1991-07-31
CA1265027A (en) 1990-01-30
WO1985003131A1 (en) 1985-07-18
DK161915C (da) 1992-02-03
BR8504686A (pt) 1985-12-24
FI853481L (fi) 1985-09-11
DE3579200D1 (de) 1990-09-20
FI84300C (fi) 1991-11-11
CS273160B2 (en) 1991-03-12
IL74256A (en) 1991-06-10
MA20326A1 (fr) 1985-10-01
ES539484A0 (es) 1987-05-01
NZ210799A (en) 1988-06-30

Similar Documents

Publication Publication Date Title
Payne et al. Interpretation of serum total calcium: effects of adjustment for albumin concentration on frequency of abnormal values and on detection of change in the individual.
Cellier et al. Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.
Epstein et al. The clinical use of alkaline phosphatase enzymes
Heller et al. A simplified assay for porphyrins in whole blood
EP0487606A1 (en) Methods and apparatus for quantifying tissue damage.
KR910006229B1 (ko) 악성 증식을 발견하기 위한 방법
Noguchi Serum diagnosis of syphilis and luetin reaction
US5366899A (en) Methods of diagnosing complicated urolithiasis and predicting urolithiasis
RU2128835C1 (ru) Способ диагностики холестаза печени с помощью электрофореза липопротеидов сыворотки крови
CN117269510A (zh) 一种诊断乳腺癌的分子标志物及其试剂盒与应用
Russell et al. B-glucuronidase activity of gastric juice in gastric carcinoma
CN116625777A (zh) 低水平冻干态糖化血红蛋白质控品及其制备方法
EP0254864A2 (en) Method for determining intracellular mineral levels
RU2147124C1 (ru) Способ оценки состояния гомеостаза
RU2137420C1 (ru) Способ выявления "группы опухолевого риска" и скрининга ранних стадий опухолевых заболеваний
EP0504409B1 (en) Method of diagnosing complicated urolithiasis and prognosticating urolithiasis
RU2104528C1 (ru) Способ определения состояния биологического материала
NO164680B (no) Fremgangsmaate for paavisning av ondartet celledeling - tumoroese sykdommer.
RU1778607C (ru) Способ цитологической диагностики злокачественных опухолей желудка
Tay et al. Recognition of cervical neoplasia by the estimation of a free-radical reaction product (octadeca-9, 11-dienoic acid) in exfoliated cells
RU2065167C1 (ru) Способ диагностики предракового состояния вульвы
KR102805190B1 (ko) 폐암 진단용 바이오마커 및 검사 대상자 임상정보를 이용한 폐암 진단을 위한 인공지능 기반 정보 제공 방법
SU1145998A1 (ru) Способ дифференциальной диагностики грибовидного микоза и дерматозов неопухолевой природы
US6383735B1 (en) Fibromyoma or carcinoma corporis uteri
Maddison et al. Serum high density lipoprotein cholesterol determination: a simple modification

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

NORF Unpaid initial registration fee
PC1904 Unpaid initial registration fee

St.27 status event code: A-2-2-U10-U13-oth-PC1904

St.27 status event code: N-2-6-B10-B12-nap-PC1904

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000